Literature DB >> 7537248

Pseudomonas aeruginosa exoenzyme S induces proliferation of human T lymphocytes.

C H Mody1, D E Buser, R M Syme, D E Woods.   

Abstract

Pseudomonas aeruginosa is a gram-negative bacterium that is responsible for devastating acute and chronic infections, which include bronchiectasis in cystic fibrosis, nosocomial pneumonia, and infection of burn wounds. Previous studies have demonstrated that these patients have impaired host responses, including cell-mediated immune responses, which are important in anti-Pseudomonas host defense. The P. aeruginosa exoproduct, exoenzyme S, has a number of characteristics which suggest that it might be important in cell-mediated immunity. To determine whether exoenzyme S activates lymphocytes to proliferate, peripheral blood mononuclear cells (PBMC) from normal volunteers were stimulated with purified exoenzyme S, and the lymphocyte response was assessed by measuring [3H]thymidine uptake and by counting the number of cells after various times in culture. Ninety-five percent of healthy adult donors had a lymphocyte response to exoenzyme S. The optimal lymphocyte response occurred on day 7, with 4 x 10(5) PBMC per microtiter well when cells were stimulated with 10 micrograms exoenzyme S per ml. [3H]thymidine uptake correlated with an increase in the number of mononuclear cells, indicating that proliferation occurred. In unseparated PBMC, T cells, and to a lesser extent B cells, proliferated. Purified T cells proliferated, while purified B cells proliferated only after the addition of irradiated T cells. Thus, T lymphocytes are necessary and sufficient for the proliferative response to exoenzyme S. We speculate that exoenzyme S from P. aeruginosa is important in T-lymphocyte-mediated host defense to P. aeruginosa. In strategies to enhance impaired cell-mediated immunity, exoenzyme S should be considered as a potential stimulant.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7537248      PMCID: PMC173227          DOI: 10.1128/iai.63.5.1800-1805.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  T lymphocyte-mediated protection against Pseudomonas aeruginosa infection in granulocytopenic mice.

Authors:  W G Powderly; G B Pier; R B Markham
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

2.  Mapping of the T-cell recognition sites of Pseudomonas aeruginosa PAK polar pili.

Authors:  W Smart; P A Sastry; W Paranchych; B Singh
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

3.  Effect of oral immunization with Pseudomonas aeruginosa on the development of specific antibacterial immunity in the lungs.

Authors:  J Freihorst; J M Merrick; P L Ogra
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

4.  In vitro T cell-mediated killing of Pseudomonas aeruginosa. II. The role of macrophages and T cell subsets in T cell killing.

Authors:  R B Markham; G B Pier; J J Goellner; S B Mizel
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

5.  Alteration of pulmonary structure by Pseudomonas aeruginosa exoenzyme S.

Authors:  D E Woods; W S Hwang; M S Shahrabadi; J U Que
Journal:  J Med Microbiol       Date:  1988-06       Impact factor: 2.472

6.  Prospective, controlled study of a polyvalent pseudomonas vaccine in cystic fibrosis--three year results.

Authors:  D T Langford; J Hiller
Journal:  Arch Dis Child       Date:  1984-12       Impact factor: 3.791

7.  In vitro and in vivo activity of polyclonal and monoclonal human immunoglobulins G, M, and A against Pseudomonas aeruginosa lipopolysaccharide.

Authors:  G B Pier; D Thomas; G Small; A Siadak; H Zweerink
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

8.  Exposure of mice to live Pseudomonas aeruginosa generates protective cell-mediated immunity in the absence of an antibody response.

Authors:  R B Markham; W G Powderly
Journal:  J Immunol       Date:  1988-03-15       Impact factor: 5.422

9.  Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sites.

Authors:  D E Woods; M S Schaffer; H R Rabin; G D Campbell; P A Sokol
Journal:  J Clin Microbiol       Date:  1986-08       Impact factor: 11.677

10.  Purification of Pseudomonas aeruginosa exoenzyme S.

Authors:  D E Woods; J U Que
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.609

View more
  7 in total

1.  Characterization of T cell clones derived from lymph nodes and lungs of Pseudomonas aeruginosa-susceptible and resistant mice following immunization with heat-killed bacteria.

Authors:  T K Kondratieva; N V Kobets; S V Khaidukov; V V Yeremeev; I V Lyadova; A S Apt; M F Tam; M M Stevenson
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  Pseudomonas aeruginosa exoenzyme S stimulates murine lymphocyte proliferation in vitro.

Authors:  N G Barclay; J C Spurrell; T F Bruno; D G Storey; D E Woods; C H Mody
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

3.  Pseudomonas aeruginosa exoenzyme S induces transcriptional expression of proinflammatory cytokines and chemokines.

Authors:  S Epelman; T F Bruno; G G Neely; D E Woods; C H Mody
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

4.  Pre-transplant Panel Reactive Antibody and Survival in Adult Cystic Fibrosis Patients After Lung Transplantation.

Authors:  Don Hayes; Dmitry Tumin; Joseph D Tobias
Journal:  Lung       Date:  2016-03-02       Impact factor: 2.584

5.  Contribution of specific Pseudomonas aeruginosa virulence factors to pathogenesis of pneumonia in a neonatal mouse model of infection.

Authors:  H B Tang; E DiMango; R Bryan; M Gambello; B H Iglewski; J B Goldberg; A Prince
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

6.  Pseudomonas aeruginosa exoenzyme S is a mitogen but not a superantigen for human T lymphocytes.

Authors:  T F Bruno; D E Buser; R M Syme; D E Woods; C H Mody
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

Review 7.  Infectious Triggers of Chronic Lung Allograft Dysfunction.

Authors:  Aric L Gregson
Journal:  Curr Infect Dis Rep       Date:  2016-07       Impact factor: 3.725

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.